Sonoma Pharmaceuticals (SNOA) Operating Leases (2019 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Operating Leases of $469000.0 for Q1 2026, up 1637.04% year-over-year from $27000.0 in Q1 2025, and down 28.4% quarter-over-quarter from $655000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Operating Leases (2019 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Operating Leases history runs 8 years deep, the most recent figure standing at $469000.0 for Q1 2026.
- In Q1 2026, Operating Leases rose 1637.04% year-over-year to $469000.0; the TTM figure through Mar 2026 stood at $469000.0 (up 1637.04% YoY), while the FY2026 annual figure was $469000.0, up 1637.04% from the prior year.
- Operating Leases for Q1 2026 stood at $469000.0, down from $655000.0 in the prior quarter.
- The five-year high for Operating Leases was $655000.0 in Q4 2025, with the low at $27000.0 in Q1 2025.
- The 5-year median for Operating Leases is $309000.0 (2022), against an average of $292647.1.
- The sharpest annual moves came in 2024 and 2026: Operating Leases slumped 86.86% in 2024, then soared 1637.04% in 2026.
- Sonoma Pharmaceuticals' Operating Leases stood at $195000.0 in 2022, then jumped by 74.87% to $341000.0 in 2023, then plunged by 65.1% to $119000.0 in 2024, then surged by 450.42% to $655000.0 in 2025, then fell by 28.4% to $469000.0 in 2026.
- Business Quant data shows SNOA's Operating Leases at $469000.0 in Q1 2026, $655000.0 in Q4 2025, and $479000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 599,000.00 |
| Mar 31, 2026 | 469,000.00 |
| Dec 31, 2025 | 655,000.00 |
| Sep 30, 2025 | 479,000.00 |
| Jun 30, 2025 | 440,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 119,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 216,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Dec 31, 2023 | 341,000.00 |
| Sep 30, 2023 | 350,000.00 |
| Jun 30, 2023 | 354,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Dec 31, 2022 | 195,000.00 |
| Sep 30, 2022 | 248,000.00 |
| Jun 30, 2022 | 478,000.00 |
| Mar 31, 2022 | 309,000.00 |
| Dec 31, 2021 | 623,000.00 |
| Sep 30, 2021 | 424,000.00 |